HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses.

AbstractPURPOSE:
To evaluate the clinical outcome of intensity-modulated radiotherapy (IMRT) in patients with mucosal melanoma (MM) of the nasal cavity and paranasal sinuses.
PATIENTS AND METHODS:
Between January 1999 and September 2004, eight patients with histologically proven MM of the nasal cavity and paranasal sinuses were treated with IMRT. A median dose of 66 Gy was applied to the macroscopic tumor (gross tumor volume [GTV]; range, 60-68 Gy) as an integrated boost and a median dose of 59 Gy (range, 54-64 Gy) to the clinical target volume (CTV) with IMRT.
RESULTS:
Treatment-related toxicity was very mild in most patients. Overall survival was 80% at 5 years. Calculated from treatment with IMRT as primary radiotherapy, survival was 100% at 1 year and 75% at 3 years. After IMRT, local progression-free survival was 71.4% at 1 year and 57.1% at 3 years, respectively. Distant progression-free survival after IMRT was 57.1% at 1 year and 28.6% at 3 years.
CONCLUSION:
Local dose escalation with IMRT yields good treatment results with respect to local and distant tumor control as well as survival, while treatment-related toxicity can be minimized.
AuthorsStephanie E Combs, Stephan Konkel, Christoph Thilmann, Jürgen Debus, Daniela Schulz-Ertner
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 183 Issue 2 Pg. 63-8 (Feb 2007) ISSN: 1439-099X [Electronic] Germany
PMID17294109 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Dose Fractionation, Radiation
  • Female
  • Humans
  • Male
  • Melanoma (radiotherapy)
  • Middle Aged
  • Nasal Cavity (radiation effects)
  • Nasal Mucosa (radiation effects)
  • Paranasal Sinus Neoplasms (radiotherapy)
  • Radiation Injuries (etiology, prevention & control)
  • Radiation Protection (methods)
  • Radiotherapy, Conformal (adverse effects, methods)
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: